GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanoviricides Inc (AMEX:NNVC) » Definitions » Shiller PE Ratio

Nanoviricides (Nanoviricides) Shiller PE Ratio : (As of Apr. 25, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Nanoviricides Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Nanoviricides Shiller PE Ratio Historical Data

The historical data trend for Nanoviricides's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanoviricides Shiller PE Ratio Chart

Nanoviricides Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nanoviricides Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nanoviricides's Shiller PE Ratio

For the Biotechnology subindustry, Nanoviricides's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanoviricides's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanoviricides's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nanoviricides's Shiller PE Ratio falls into.



Nanoviricides Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Nanoviricides's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Nanoviricides's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.18/129.4194*129.4194
=-0.180

Current CPI (Dec. 2023) = 129.4194.

Nanoviricides Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.400 99.695 -0.519
201406 -2.800 100.560 -3.604
201409 0.400 100.428 0.515
201412 -0.800 99.070 -1.045
201503 -0.400 99.621 -0.520
201506 -0.400 100.684 -0.514
201509 -0.400 100.392 -0.516
201512 -1.000 99.792 -1.297
201603 -1.800 100.470 -2.319
201606 -0.600 101.688 -0.764
201609 -1.000 101.861 -1.271
201612 -0.600 101.863 -0.762
201703 -1.000 102.862 -1.258
201706 -0.800 103.349 -1.002
201709 -0.600 104.136 -0.746
201712 -0.800 104.011 -0.995
201803 -0.600 105.290 -0.738
201806 -0.440 106.317 -0.536
201809 -0.530 106.507 -0.644
201812 -0.640 105.998 -0.781
201903 -0.590 107.251 -0.712
201906 -0.580 108.070 -0.695
201909 -0.410 108.329 -0.490
201912 -0.500 108.420 -0.597
202003 -1.240 108.902 -1.474
202006 0.060 108.767 0.071
202009 -0.220 109.815 -0.259
202012 -0.220 109.897 -0.259
202103 -0.190 111.754 -0.220
202106 -0.180 114.631 -0.203
202109 -0.230 115.734 -0.257
202112 -0.170 117.630 -0.187
202203 -0.160 121.301 -0.171
202206 -0.150 125.017 -0.155
202209 -0.140 125.227 -0.145
202212 -0.150 125.222 -0.155
202303 -0.150 127.348 -0.152
202306 -0.310 128.729 -0.312
202309 -0.170 129.860 -0.169
202312 -0.180 129.419 -0.180

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Nanoviricides  (AMEX:NNVC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Nanoviricides Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Nanoviricides's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanoviricides (Nanoviricides) Business Description

Traded in Other Exchanges
Address
1 Controls Drive, Shelton, CT, USA, 06484
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Executives
Makarand Jawadakar director C.O NANOVIRICIDES, INC, 1 CONTROLS DRIVE, SHELTON CT 06484
Mark D. Day director C/O NANOVIRICIDES, INC., 1 CONTROLS DRIVE, SHELTON CT 06484
Milton Boniuk director C/O NANOVIRICIDES, INC., 135 WOOD STREET, SUITE 205, WEST HAVEN CT 06516
Anil Diwan director, 10 percent owner, officer: President 135 WOOD STREET, SUITE 205, WEST HAVEN CT 06516
Mukund S Kulkarni director C/O NANOVIRICIDES, INC., 135 WOOD ST, SUITE 205, WEST HAVEN CT 06516
Meeta Vyas officer: Chief Financial Officer 135 WOOD STREET, SUITE 205, WEST HAVEN CT 06516
Eugene Seymour director, 10 percent owner 666 THIRD AVENUE, NEW YORK NY 10017
Theracour Pharma, Inc. 10 percent owner 135 WOOD STREET, SUITE 205, WEST HAVEN CT 06516

Nanoviricides (Nanoviricides) Headlines